Literature DB >> 6752562

Adverse reactions to intravenous agents in anaesthesia in France.

M C Laxenaire, D A Moneret-Vautrin, S Boileau, R Moeller.   

Abstract

One hundred severe peranesthetic accidents occurring in hospitals in the eastern part of France were tested between 1975 and 1980 at the Immunological Unit of the University Hospital in Nancy. Tests were carried out "a posteriori"; mean time: three weeks after the accident (extremes: one week to one year). A second battery of tests was carried out in 35%, and a third one in 8% of the patients. Anaphylaxis was differentiated from anaphylactoid reactions be means of the tests. Responsible drugs were determined by intradermal testing, by the human basophil degranulation test and P.K. tests. Predisposing factors were studied: atopy (IgE dosage), increase of histamine release (intradermal testing with 48/80), abnormal receptivity to histamine (intradermal histamine), spasmophilia (electromyography recordings). The results show that 42 accidents were due to true anaphylaxis (one of them due to IgG); 48% of the reported accidents were due to succinylcholine. Some of the predisposing factors, in the tested population, are found in a higher proportion than in the French population as a whole; atopy, hypersensitivity to histamine, previous drug allergy, spasmophilia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752562     DOI: 10.1007/bf01716963

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  10 in total

1.  [What prevents the diagnosis of spasmphilia].

Authors:  M Duc; M L Duc
Journal:  Ann Anesthesiol Fr       Date:  1976

2.  [Skin tests for 48/80 and histamine].

Authors:  P Pupil; M Berna
Journal:  Ann Anesthesiol Fr       Date:  1976

3.  Intradermal testing in the diagnosis of acute anaphylaxis during anaesthesia--results of five years experience.

Authors:  M M Fisher
Journal:  Anaesth Intensive Care       Date:  1979-02       Impact factor: 1.669

Review 4.  Anaphylactoid reactions to i.v. substances.

Authors:  J Watkins
Journal:  Br J Anaesth       Date:  1979-01       Impact factor: 9.166

5.  [Anaphylactic type of accidents due to myorelaxing agents during general anesthesia. Clinical and biological study].

Authors:  D Vervloet; A Arnaud; P Vellieux; S Kaplanski; J Charpin
Journal:  Nouv Presse Med       Date:  1977-03-05

6.  [Various risk factors in the precipitaiton of complications caused by anesthetics and muscle relaxants].

Authors:  D A Moneret DA Vautrin; M Duc; M Sigiel
Journal:  Ann Anesthesiol Fr       Date:  1976

7.  [Human basophil degranulation test: significance for the diagnosis of anaphylaxis caused by succinylcholine].

Authors:  D A Moneret-Vautrin; J P Grilliat; D L'Hoste; M C Laxenaire
Journal:  Nouv Presse Med       Date:  1978-10-28

8.  Anaphylaxis due to succinylcholine. Immunoallergological study of thirteen cases.

Authors:  D A Moneret-Vautrin; M C Laxenaire; R Moeller
Journal:  Clin Allergy       Date:  1981-03

9.  Reaginic antibodies to drugs used in anesthesia.

Authors:  M M Fisher
Journal:  Anesthesiology       Date:  1980-04       Impact factor: 7.892

10.  [Prevention of complications of histamine liberation occurring after administration of anesthetic agents and adjuvants].

Authors:  M C Laxenaire; A Chastel; J Borgo; K M Kim; A Medot; J M Fossard; J Barlier
Journal:  Ann Anesthesiol Fr       Date:  1977
  10 in total
  4 in total

Review 1.  Anaphylactoid reactions to intravenous solutions used for volume substitution.

Authors:  J Ring
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

Review 2.  Risk factors for allergic or pseudoallergic reactions in the perioperative period.

Authors:  D Charpin; M Pradal; D Vervloet
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

Review 3.  Anaphylactic and anaphylactoid reactions due to anesthetic agents.

Authors:  M Schatz; D L Fung
Journal:  Clin Rev Allergy       Date:  1986-05

Review 4.  Anaphylaxis during the perioperative period.

Authors:  Shrikant Mali
Journal:  Anesth Essays Res       Date:  2012 Jul-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.